BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9038732)

  • 1. p53 expression in carcinoma of the cervix.
    Hunt CR; Hale RJ; Buckley CH; Hunt J
    J Clin Pathol; 1996 Dec; 49(12):971-4. PubMed ID: 9038732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical squamous dysplasias and carcinomas with immunodetectable p53 frequently contain HPV.
    Mittal KR; Lin O; Chan W; Goswami S; Demopoulos RI
    Gynecol Oncol; 1995 Sep; 58(3):289-94. PubMed ID: 7672694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P53 immunohistochemical expression: messages in cervical carcinogenesis.
    Cheah PL; Looi LM
    Pathology; 2002 Aug; 34(4):326-31. PubMed ID: 12190289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue expression of human epididymal secretory protein 4 may be useful in the differential diagnosis of uterine cervical tumors.
    Diniz G; Karadeniz T; Sayhan S; Akata T; Aydiner F; Ayaz D; Solakoglu Kahraman D; Akman T
    Ginekol Pol; 2017; 88(2):51-55. PubMed ID: 28326512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of 14-3-3 sigma protein in various histological subtypes of uterine cervical cancers.
    Sano T; Shimooka H; Weixa P; Segawa A; Jian Z; Motegi A; Nakayama H; Oyama T; Nakajima T
    Pathol Int; 2004 Oct; 54(10):743-50. PubMed ID: 15482563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of expression of enhancer of zeste homolog 2 and 53 in cervical squamous cell carcinoma and intraepithelial neoplasia].
    Zhang H; Chen S; Niu G; Jiang H; Yao S
    Zhonghua Zhong Liu Za Zhi; 2014 Aug; 36(8):597-601. PubMed ID: 25430026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between retinoblastoma and p53 proteins in human papilloma viruses 16/18 positive and negative cancers of the uterine cervix.
    Chetty R; Bramdev A; Aguirre-Arteta A; Pegoraro RJ; Sataar N
    J Clin Pathol; 1997 May; 50(5):413-6. PubMed ID: 9215125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of p53 expression in early stage cervical carcinoma treated by surgery.
    Khunamornpong S; Siriaunkgul S; Manusirivithaya S; Settakorn J; Srisomboon J; Ponjaroen J; Thorner PS
    Asian Pac J Cancer Prev; 2008; 9(1):48-52. PubMed ID: 18439073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of p53, bcl-2 and Ki-67 in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix.
    Looi ML; Dali AZ; Ali SA; Ngah WZ; Yusof YA
    Anal Quant Cytol Histol; 2008 Apr; 30(2):63-70. PubMed ID: 18561741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of ezrin and galectin-3 as predictors of poor prognosis of cervical cancer.
    Li M; Feng YM; Fang SQ
    Braz J Med Biol Res; 2017 Mar; 50(4):e5356. PubMed ID: 28355349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of heat shock protein 27 in squamous cell carcinoma of the uterine cervix: a proteomic analysis using archival formalin-fixed, paraffin-embedded tissues.
    Ono A; Kumai T; Koizumi H; Nishikawa H; Kobayashi S; Tadokoro M
    Hum Pathol; 2009 Jan; 40(1):41-9. PubMed ID: 18755499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of nm23-H1 and c-erbB-2 proteins have prognostic significance in adenocarcinoma but not in squamous cell carcinoma of the uterine cervix.
    Mandai M; Konishi I; Koshiyama M; Komatsu T; Yamamoto S; Nanbu K; Mori T; Fukumoto M
    Cancer; 1995 May; 75(10):2523-9. PubMed ID: 7736397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunohistochemical analysis of sex-steroid receptors, tumor suppressor gene p53 and Ki-67 in the normal and neoplastic uterine cervix squamous epithelium.
    Nikolaou M; Koumoundourou D; Ravazoula P; Papadopoulou M; Michail G; Decavalas G
    Med Pregl; 2014; 67(7-8):202-7. PubMed ID: 25151759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research on expression and importance of p53, p16 and VEGF-C in cervical cancer.
    Cai S; Han K
    J Gynecol Obstet Biol Reprod (Paris); 2015 Sep; 44(7):639-45. PubMed ID: 25443468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of vascular endothelial growth factor in the progression of cervical neoplasia and its relation to angiogenesis and p53 status.
    Lee JS; Kim HS; Park JT; Lee MC; Park CS
    Anal Quant Cytol Histol; 2003 Dec; 25(6):303-11. PubMed ID: 14714296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syndecan-1 expression in cancer of the uterine cervix: association with lymph node metastasis.
    Numa F; Hirabayashi K; Kawasaki K; Sakaguchi Y; Sugino N; Suehiro Y; Suminami Y; Hirakawa H; Umayahara K; Nawata S; Ogata H; Kato H
    Int J Oncol; 2002 Jan; 20(1):39-43. PubMed ID: 11743640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia.
    Dellas A; Schultheiss E; Almendral AC; Gudat F; Oberholzer M; Feichter G; Moch H; Torhorst J
    Int J Cancer; 1997 Aug; 74(4):421-5. PubMed ID: 9291432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of Wnt-11 and squamous cell carcinoma antigen expression in cervical cancer.
    Wei H; Wang N; Zhang Y; Wang S; Pang X; Zhang J; Luo Q; Su Y; Zhang S
    Med Oncol; 2014 May; 31(5):933. PubMed ID: 24737009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical localization of cdc6 in squamous and glandular neoplasia of the uterine cervix.
    Bonds L; Baker P; Gup C; Shroyer KR
    Arch Pathol Lab Med; 2002 Oct; 126(10):1164-8. PubMed ID: 12296751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of the protein marker p16INK4a in the cervix uteri cancer].
    Volgareva GM; Zavalishina LE; Frank GA; Andreeva IuIu; Petrov AN; Kiselev FL; SpitkovskiÄ­ DD
    Arkh Patol; 2002; 64(1):22-4. PubMed ID: 11889694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.